|
|
40
|
|
|
5641N
|
|
|
ZINACEF 1.5G INJ (GSK/COL) CEFUROXIME
|
|
|
CEFUROXIME
|
|
|
ZINACEF
|
|
|
1.5G VIAL
|
|
|
C
|
|
|
18.38
|
|
|
18.38
|
|
|
1.5G
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
GSK
|
|
|
GLAXOSMITHKLINE
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
Yes
|
|
|
08120608
|
|
|
SECOND GEN CEPHALOSPORINS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTI-INFECTIVE AGENTS
|
|
|
|